文献速递肿瘤 PET/CT核素与放射性配体治疗

肝脏肿瘤的分子影像与治疗

Molecular Imaging and Therapy of Liver Tumors.
PubMed 文献 · Semin Nucl Med · 2020-06-09

综述指出肝癌是全球主要死因之一,增强CT和MRI仍是肝脏肿瘤影像诊断与管理的主要手段;近二十年来PET/CT和SPECT/CT等混合成像推动了分子影像在肝脏肿瘤中的应用,除FDG外,放射性标记胆碱示踪剂、C-11乙酸盐及其他新型示踪剂证据不断积累;治疗方面,经动脉放射性栓塞等靶向治疗取得进展,诊疗一体化概念可通过治疗前规划扫描(如Tc-99m大颗粒聚合白蛋白显像)结合治疗后影像应用于经动脉放射性栓塞,并提倡基于个体化剂量计算制定肝脏肿瘤的辐射剂量计划。

要点

  • 增强CT和MRI仍是肝脏肿瘤影像诊断与管理的主要手段。
  • 除FDG外,放射性标记胆碱、C-11乙酸盐等示踪剂在肝脏肿瘤成像中证据增加。
  • 经动脉放射性栓塞可借助Tc-99m大颗粒聚合白蛋白规划扫描实现诊疗一体化。

核心结论

  • 分子影像与靶向治疗在肝脏肿瘤诊疗中应用日益增多,诊疗一体化与个体化剂量计算受到提倡。

研究设计与样本

  • 综述类文章,围绕核医学在肝癌影像与治疗领域超越常规诊疗的趋势进行探讨。

主要发现

  • 近二十年PET/CT和SPECT/CT等混合成像推动分子影像更多用于肝脏肿瘤成像。
  • 除FDG外,放射性标记胆碱示踪剂、C-11乙酸盐及其他新型示踪剂在肝脏肿瘤成像中的证据不断积累。
  • 原发性与继发性肝脏恶性肿瘤的靶向治疗取得进展,尤其是经动脉放射性栓塞。
  • 诊疗一体化概念可通过治疗前Tc-99m大颗粒聚合白蛋白规划扫描联合治疗后影像应用于经动脉放射性栓塞。
  • 提倡通过个体化剂量计算为肝脏肿瘤制定辐射剂量计划。

临床怎么用

  • 肝脏肿瘤核医学成像除FDG外可关注放射性标记胆碱、C-11乙酸盐等示踪剂。
  • 经动脉放射性栓塞可借助Tc-99m大颗粒聚合白蛋白治疗前规划扫描联合治疗后影像。
  • 可考虑个体化剂量计算制定肝脏肿瘤辐射剂量计划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Liver cancer is one of the top leading causes of mortality worldwide. Conventional imaging using contrast enhanced CT and MRI are currently the mainstay of oncologic imaging of the liver for the diagnosis and management of cancer. In the past two decades, especially since the advent of hybrid imaging in the form of PET/CT and SPECT/CT, molecular imaging has been increasingly utilized for oncologic imaging and the variety of radionuclide probes for imaging liver cancers have been expanding. Beyond the usual workhorse of FDG as an oncologic tracer, there is a growing body of evidence showing that radiolabeled choline tracers, C-11 acetate and other new novel tracers may have increasing roles to play for the imaging of liver tumors. On the therapy front, there have also been advances in recent times in terms of targeted therapies for both primary and secondary liver malignancies, particularly with transarterial radioembolization. The concept of theranostics can be applied to transarterial radioembolization by utilizing a pretreatment planning scan, such as Tc-99m macroaggregated albumin scintigraphy, coupled with post treatment imaging. Radiation dose planning by personalized dosimetric calculations to the liver tumors is also being advocated. This article explores the general trends in the field of nuclear medicine for the imaging and treatment of liver cancer above and beyond routine diagnosis and management.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Tong AK, Tham WY, Too CW, et al. Molecular Imaging and Therapy of Liver Tumors. Semin Nucl Med. 2020. PMID: 32768006. doi:10.1053/j.semnuclmed.2020.04.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。